Mycobacterium avium-intracellulare Infection
Information
- Disease name
- Mycobacterium avium-intracellulare Infection
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00000641 | Completed | Phase 2 | A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals. | December 1994 | |
| NCT00000644 | Completed | Phase 2 | A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS | ||
| NCT00000860 | Completed | The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients | |||
| NCT00000883 | Completed | N/A | Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy | October 1997 | April 2007 |
| NCT00000895 | Completed | N/A | A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection | August 2001 | |
| NCT00000907 | Completed | A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients | |||
| NCT00000933 | Completed | Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048 | July 2000 | ||
| NCT00000947 | Completed | N/A | A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients | July 2000 | |
| NCT00000971 | Completed | Phase 1 | The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS | ||
| NCT00001023 | Completed | N/A | The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected Patients | July 1998 | |
| NCT00001030 | Completed | Phase 3 | The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients | June 1996 | |
| NCT00001039 | Completed | Phase 2 | Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients | June 2002 | |
| NCT00001047 | Completed | Phase 3 | Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS | August 1996 | |
| NCT00001058 | Completed | Phase 2 | A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS | January 1999 | |
| NCT00001763 | Completed | Phase 1 | Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection | April 1998 | March 2000 |
| NCT00001995 | Completed | N/A | A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS | ||
| NCT00002032 | Completed | N/A | Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial | ||
| NCT00002037 | Completed | N/A | Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study | ||
| NCT00002058 | Completed | N/A | A Randomized Controlled Prophylactic Study of Clofazimine To Prevent Mycobacterium Avium Complex Infection in HIV Disease | ||
| NCT00002080 | Completed | N/A | Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study | ||
| NCT00002085 | Completed | N/A | A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy | ||
| NCT00002089 | Completed | N/A | An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy | ||
| NCT00002090 | Completed | N/A | An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS) | ||
| NCT00002101 | Completed | Phase 3 | A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo | ||
| NCT00002104 | Completed | Phase 1 | Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV | ||
| NCT00002122 | Completed | Phase 3 | A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients | ||
| NCT00002140 | Completed | Phase 3 | A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients | ||
| NCT00002170 | Completed | Phase 2 | A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC) | ||
| NCT00002192 | Completed | Phase 2 | Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia. | ||
| NCT00002267 | Completed | N/A | Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial | ||
| NCT00002309 | Completed | N/A | A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients | ||
| NCT00002343 | Completed | Phase 4 | A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS | ||
| NCT00004689 | Completed | Phase 2 | Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease | January 1991 | September 1998 |
| NCT00021567 | Completed | Phase 2 | A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections | July 2001 | June 2002 |
| NCT00111397 | Completed | Phase 1 | Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex Infection | May 13, 2005 | August 4, 2010 |
| NCT05824988 | Recruiting | Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease | April 14, 2023 | October 2026 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D015270